Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation
Publication date: Available online 21 October 2026 Source: American Journal of Kidney Diseases Author(s): Wolfgang C. Winkelmayer, Maria E. Montez-Rath, Mingyue He, Kevin F. Erickson, L. Parker Gregg, Pascale Khairallah, Glenn M. Chertow, Tara I. Chang, Jingbo Niu
Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0272638626011777?dgcid=rss_sd_all
Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0272638626011777?dgcid=rss_sd_all
“Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation.” American Journal of Kidney Diseases.
@article{article34541,
title = {Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0272638626011777?dgcid=rss_sd_all}
}
ABSTRACT Approximately 5% of patients who develop renal rupture lack an identifiable underlying lesion, such as tumours, hydronephrosis, or vascular malformations. In this case report, we detail a case with a left renal rupture of a...
ABSTRACT Aim Both high and low body mass index (BMI) have been reported to be associated with a higher risk of chronic kidney disease (CKD) progression. However, whether this association varies across CKD stages remains unclear. We...
Nature Reviews Nephrology, Published online: 17 November 2026; doi:10.1038/s41581-026-01151-4 The concept of cardiovascular–kidney–metabolic (CKM) syndrome supports an integrated, multidisciplinary approach to improve patient outcomes....
ABSTRACT Introduction Patients on hemodialysis have an increased risk of sudden cardiac death and an increased cardiac arrhythmia burden due to large fluid and electrolyte shifts, especially during the long inter‐dialytic period....